CDKN2A and neoplasm: Notably, OIS appears to be further enhanced with increased simultaneous expression of p16 and p53, whereas Kras cooperates with genetic inactivation of those key senescence signaling pathways to accelerate tumorigenesis [66], highlighting the protective effect of senescence against tumor progression [78].